What Happened to Theranos Inc.?

Theranos Inc. was founded in 2003 by Elizabeth Holmes, a Stanford University dropout, with the ambitious goal of revolutionizing blood testing. The company claimed its proprietary 'Edison' device could perform a wide range of tests using only a few drops of blood from a fingerprick, promising faster, cheaper, and more accessible diagnostics. This vision attracted significant investment, raising over $700 million from venture capitalists and private investors, and propelling Theranos to a peak valuation of $9 billion by 2014, making Holmes the youngest self-made female billionaire.

The fraud began to unravel in 2015 when investigative journalist John Carreyrou of The Wall Street Journal published a series of articles questioning the validity of Theranos' technology. These reports, based on interviews with former employees and internal documents, revealed that the company was largely using traditional blood testing machines from other manufacturers and that its Edison devices were unreliable and inaccurate.

Key turning points included regulatory scrutiny from the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA), which found significant deficiencies in Theranos' labs and practices. In 2016, Walgreens, a major partner that had invested $140 million and hosted Theranos wellness centers, terminated its partnership.

In March 2018, the U.S. Securities and Exchange Commission (SEC) charged Holmes and Balwani with 'massive fraud' for deceiving investors. Holmes settled civil charges, agreeing to pay a $500,000 fine, forfeit millions of shares, and be barred from serving as an officer or director of a public company for ten years. Federal grand juries later indicted Holmes and Balwani on criminal wire fraud charges. Theranos officially ceased operations and dissolved in September 2018.

The legal consequences were severe. Elizabeth Holmes' trial began in August 2021 and concluded in January 2022, with a jury finding her guilty on four counts of defrauding investors, while acquitting her of defrauding patients. In November 2022, Holmes was sentenced to 11 years and 3 months (135 months) in federal prison and ordered to pay $452 million in restitution jointly with Balwani. She reported to Federal Prison Camp, Bryan, Texas, on May 30, 2023.

Ramesh 'Sunny' Balwani, Theranos' former President and COO, was tried separately and convicted on all 12 counts of fraud and conspiracy in July 2022. He was sentenced to 12 years and 11 months (155 months) in prison in December 2022 and began his sentence at FCI Terminal Island in San Pedro, California, on April 20, 2023, after losing appeals to remain free.

As of June 2026, Elizabeth Holmes' legal battles continue. In February 2025, the Ninth Circuit Court of Appeals rejected her arguments and affirmed her conviction, sentence, and restitution obligation. In December 2025, reports emerged that Holmes had begun campaigning for a presidential pardon from President Donald Trump, and she formally requested clemency in January 2026, which remains under review. In March 2026, Judge Davila reduced Holmes' sentence by 12 months, citing revised federal sentencing guidelines. Balwani's appeals were also rejected by the Ninth Circuit in February 2025. The Theranos saga serves as a cautionary tale about unchecked ambition, the dangers of 'fake it till you make it' culture in Silicon Valley, and the critical importance of scientific validation and ethical conduct in healthcare.